These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
649 related articles for article (PubMed ID: 8770161)
1. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors. Feng JJ; Arendshorst WJ Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161 [TBL] [Abstract][Full Text] [Related]
2. Calcium signaling mechanisms in renal vascular responses to vasopressin in genetic hypertension. Feng JJ; Arendshorst WJ Hypertension; 1997 Nov; 30(5):1223-31. PubMed ID: 9369280 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of V(1) receptors in renal resistance vessels of rats developing genetic hypertension. Vågnes O; Feng JJ; Iversen BM; Arendshorst WJ Am J Physiol Renal Physiol; 2000 Jun; 278(6):F940-8. PubMed ID: 10836981 [TBL] [Abstract][Full Text] [Related]
4. Renal hemodynamics in young and old spontaneously hypertensive rats during intrarenal infusion of arginine vasopressin. Christiansen RE; Roald AB; Gjerstad C; Tenstad O; Iversen BM Kidney Blood Press Res; 2001; 24(3):176-84. PubMed ID: 11528210 [TBL] [Abstract][Full Text] [Related]
5. Control of renal medullary blood flow by vasopressin V1 and V2 receptors. Nakanishi K; Mattson DL; Gross V; Roman RJ; Cowley AW Am J Physiol; 1995 Jul; 269(1 Pt 2):R193-200. PubMed ID: 7631893 [TBL] [Abstract][Full Text] [Related]
6. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Chatziantoniou C; Daniels FH; Arendshorst WJ Am J Physiol; 1990 Aug; 259(2 Pt 2):F372-82. PubMed ID: 2386211 [TBL] [Abstract][Full Text] [Related]
7. Coronary vasoconstriction produced by vasopressin in anesthetized goats. Role of vasopressin V1 and V2 receptors and nitric oxide. Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G Eur J Pharmacol; 1998 Jan; 342(2-3):225-33. PubMed ID: 9548390 [TBL] [Abstract][Full Text] [Related]
8. Enhanced Ca2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states. Vagnes OB; Hansen FH; Feng JJ; Iversen BM; Arendshorst WJ Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1249-56. PubMed ID: 15657301 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of V2 vasopressin agonist and antagonists on blood pressure regulation in normotensive (WKY) and spontaneously hypertensive (SHR) rats. Budzikowski A; Lon S; Paczwa P; Szczepanska-Sadowska E J Auton Nerv Syst; 1992 Jun; 39(2):87-95. PubMed ID: 1430797 [TBL] [Abstract][Full Text] [Related]
10. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system. Croiset G; De Wied D Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858 [TBL] [Abstract][Full Text] [Related]
11. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats. Januszewicz A; Lapiński M; Styś T; Styś A; Loń S Pol J Pharmacol; 1994; 46(3):153-61. PubMed ID: 8000447 [TBL] [Abstract][Full Text] [Related]
12. Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats. Chatziantoniou C; Arendshorst WJ Am J Physiol; 1992 Oct; 263(4 Pt 2):F573-80. PubMed ID: 1329556 [TBL] [Abstract][Full Text] [Related]
13. Central V1 AVP receptors are involved in cardiovascular adaptation to hypovolemia in WKY but not in SHR. Budzikowski AS; Paczwa P; Szczepańska-Sadowska E Am J Physiol; 1996 Sep; 271(3 Pt 2):H1057-64. PubMed ID: 8853341 [TBL] [Abstract][Full Text] [Related]
14. Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors. Yamauchi T; Ogura T; Oishi T; Harada K; Hashimoto M; Mimura Y; Asano N; Ota Z; Kageyama J Acta Med Okayama; 1995 Feb; 49(1):53-9. PubMed ID: 7762410 [TBL] [Abstract][Full Text] [Related]
15. Impaired potentiation by endothelin-1 and vasopressin of sympathetic contraction in tail artery from hypertensive rats. García-Villalón AL; Monge L; Fernández N; Sánchez MA; Martínez MA; Gómez B; Diéguez G Cardiovasc Res; 2000 Jan; 45(2):463-9. PubMed ID: 10728367 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide, but not vasopressin V2 receptor-mediated vasodilation, modulates vasopressin-induced renal vasoconstriction in rats. Loichot C; Cazaubon C; De Jong W; Helwig JJ; Nisato D; Imbs JL; Barthelmebs M Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):319-26. PubMed ID: 10731046 [TBL] [Abstract][Full Text] [Related]
18. Renal vascular reactivity to vasodilator prostaglandins in genetically hypertensive rats. Chatziantoniou C; Arendshorst WJ Am J Physiol; 1992 Jan; 262(1 Pt 2):F124-30. PubMed ID: 1733288 [TBL] [Abstract][Full Text] [Related]
19. Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat. Hansen FH; Vågnes ØB; Iversen BM Am J Physiol Renal Physiol; 2005 May; 288(5):F1023-31. PubMed ID: 15598845 [TBL] [Abstract][Full Text] [Related]
20. Endothelium-dependent relaxation of human saphenous veins in response to vasopressin and desmopressin. Aldasoro M; Medina P; Vila JM; Otero E; Martinez-León JB; Lluch S J Vasc Surg; 1997 Apr; 25(4):696-703. PubMed ID: 9129626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]